Steve Bernstein
Analyst · the Securities and Exchange Commission. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this conference call. It is now my pleasure to introduce your host, Thomas McClelland, President and Chief Executive Officer
Thank you, Tom, and good afternoon. For the three months ended July 31, 2022, consolidated revenue was $8.2 million compared to $13 million for the same period of the prior fiscal year. The components of revenue are as follows: Revenue from commercial and U.S. government satellite programs was approximately $3.5 million, or 42%, compared to $6.7 million, or 52%, in the same period of the prior fiscal year. Revenues on satellite payload contracts are recognized primarily under the percentage of completion method and are recorded only in the FEI-New York segment. Revenues from non-space U.S. government and DOD customers, which are recorded in both the FEI-New York and FEI-Zyfer segments were $4.1 million compared to $5.5 million in the same period of the prior fiscal year and accounted for approximately 50% of consolidated revenue compared to 42% for the prior fiscal year. Other commercial and industrial revenues were $664,000 compared to $724,000 in in the prior fiscal year. Intersegment revenues are eliminated in consolidation. For the three months ended July 31, 2022, gross margin and gross margin rate decreased as compared to the same period in fiscal year '22. The decrease in gross margin and gross margin rate was due to increased engineering costs on development phase programs that experience particularly complex technical challenges as well as cost impacts on several programs resulting from supply chain problems. Gross margin was also affected by underabsorption of cost due to the decrease in sales this quarter. For the three months ended July 31, '22 and '21, selling and administrative expenses were approximately 24% and 34%, respectively, of consolidated revenues. The decrease in SG&A expense for the three months ended July 31, '22, as compared to the prior year period end is largely due to decrease in professional fees as well as a reduction in stock option expense and deferred compensation expense. R&D expense for the three months ended July 31, '22, decreased to $1.1 million from $1.4 million for the three months ended July 31, a decrease of $300,000 and were approximately 14% and 10% of consolidated revenue. R&D decreases for the first quarter of fiscal year '23 are related to focus on projects currently in production phase. The company plans to continue to invest in R&D in the future to keep its products at the state of the art. For the three months ended July 31, '22, the company reported an operating loss of $3.1 million compared to an operating loss of $1.7 million in the prior year. Operating losses resulted largely from the decrease in revenue, coupled with the additional costs mentioned previously regarding gross margin. Other income consisted primarily of investment income derived from the company's holdings and marketable securities. Earnings on securities may vary based on fluctuating interest rates, dividend payout levels and the timing of purchases, sales, redemptions or maturities of securities. This yields a pretax loss of approximately $3.1 million compared to $1.6 million pretax loss for the prior fiscal year. For the three months ended July 31, '22 and '21, the company recorded a tax provision of $1,000. Consolidated net loss for the 3 months ended July 31, '22 was $3.1 million or $0.33 per share compared to $1.6 million net loss or $0.17 per share in the prior fiscal year. Our fully funded backlog at the end of July '22 was approximately $40 million, similar to the previous fiscal year-end, April 30, '22. The company's balance sheet continues to reflect the strong working capital position of approximately $31 million at July 31, '22 and a current ratio of approximately 2.3 to 1. Additionally, the company is debt-free. The company believes that its liquidity is adequate to meet its operating investing needs for the next 12 months and the foreseeable future. I will turn the call back to Tom, and we look forward to your questions.